CFLAR and thyroid cancer: FLIP antisense oligonucleotides and cycloheximide decreased FLIP protein and restored TRAIL sensitivity in human multiple myeloma cells and thyroid cancer cell lines (Mitsiades et al, 2002; Poulaki et al, 2002).